CoRISMA is a stage medical device company based in New Haven, CT, spun out of the Bonde Artificial Heart Lab at Yale and founded in 2018. The company has advanced a transcatheter, implantable cardiac treatment device that features wirelessly powered mechanical circulatory support. CoRISMA is led by CEO Mike Theran and Pramod Bonde. The company raised $27M in a Series A to accelerate development and expand availability of its cardiac treatment device. The financing is intended to support product development and broader availability efforts. No operating metrics or revenue figures were disclosed in the article.

Total raised

$27M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2021